Citation Impact
Citing Papers
Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
2007 StandoutNobel
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
1989 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Fatigue among Clinicians and the Safety of Patients
2002 Standout
Testicular Germ-Cell Cancer
1997 Standout
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents
1997
Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North America
2002
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell Tumors
1990
Imaging in the era of molecular oncology
2008 StandoutNature
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma
1989
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Selection of large diversities of antiidiotypic antibody fragments by phage display
2002 StandoutNobel
Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.
1992
A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
1992
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.
1998
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
The mighty mouse: genetically engineered mouse models in cancer drug development
2006
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
1993
Malignant Gliomas in Adults
2008 Standout
Carboplatin: current status and future prospects
1988
Na+/H+ exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation
1989
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.
1991
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer
1992
Infectious and immunosuppressive complications of purine analog therapy.
1995
How to calculate the dose of chemotherapy
2002
Chemotherapy for Malignant Pleural Mesothelioma
2003
Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
1990
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
1993
A Model to Select Chemotherapy Regimens for Phase III Trials for Extensive-Stage Small-Cell Lung Cancer
2000
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
1991 Standout
Clinical Pharmacokinetics of Interferons
1990
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
A Review of Chemotherapy Trials for Malignant Mesothelioma
1998
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
2006 Standout
Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.
1995
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate
1993
Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma
1989
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
2015
Advances in Malignant Mesothelioma
2005 Standout
Brain Tumors
2001 Standout
Cancer of the Ovary
2004 Standout
Multiparametric Flow Cytometric Analysis of Inter-Patient Variation in STAT1 Phosphorylation Following Interferon Alfa Immunotherapy
2004
Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.
1996
Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.
1981
Tumour stem cells and drug resistance
2005 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
2008
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
1986
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
High-Dose Cisplatin in Hypertonic Saline
1984
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
1987 Standout
Graduate Medical Education Reform
1994
Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
1999
Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimen
1983
Evolution of the Management of Stage I Nonseminomatous Germ-cell Tumors of the Testis
1991
Klinefelter's syndrome associated with mediastinal germ cell neoplasms.
1987
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
The pathogenesis of cancer metastasis
1980 StandoutNature
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
The treatment of soft tissue sarcomas with focus on chemotherapy: A review
1986
Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities
1983
Epithelial Carcinoma of the Ovary: Current Strategies
1981
The Biology of Cancer Invasion and Metastasis
1978
HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.
1994 StandoutNobel
The Anthracycline Antineoplastic Drugs
1981 Standout
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.
1985
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
2002
Chemotherapy of advanced soft-tissue sarcomas in adults
1977
Cisplatin
1984 Standout
DNA Topoisomerases: Structure, Function, and Mechanism
2001 Standout
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001
Dose translation from animal to human studies revisited
2007 Standout
Works of Michael K. Samson being referenced
Phase II Study of Intravenous Bolus Recombinant Interleukin-2 in Advanced Malignant Melanoma: Southwest Oncology Group Study
1991
A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
1991
Evaluation of amonafide in disseminated malignant melanoma
1993
Evaluation of fludarabine phosphate in malignant melanoma
1991
The Role of Physician-Assistants in Critical Care Units
1991
Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha2 interferon in patients with malignancies
1984
Combination chemotherapy, radiotherapy, and BCG immunotherapy in extensive (metastatic) small cell carcinoma of the lung. A southwest oncology group study
1980
Vinblastine, bleomycin and Cis-diamminedichloroplatinum in disseminated testicular cancer: Response to treatment and prognostic correlations
1980
VM26 (NSC-122819): A clinical study in advanced cancer of the lung and ovary
1978
Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.
1980
Aclacinomycin A Phase II Evaluation in Advanced Soft Tissue Sarcoma
1987
Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study.
1984
Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: A Southwest Oncology group study
1982
The effect of amiloride on hormonal regulation of amino acid transport in isolated and cultured adult rat hepatocytes
1981
CBDCA
1987
Mitomycin C in advanced adenocarcinoma and large cell carcinoma of the lung.
1978
Alterations in plasma sialyltransferase associated with successful chemotherapy of a disseminated tumor.Case report
1976
Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 days.
1976
Fludarabine Phosphate Phase II Evaluation in Advanced Soft-Tissue Sarcomas
1987
Acquired hypertrichosis lanuginosa.Report of two new cases and a review of the literature
1975
Combination preoperative radiation and chemotherapy in adenocarcinoma of the rectum
1976
Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study
1984
A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A Southwest oncology group study
1975
Vinblastine (VLB), bleomycin (BLEO), cis-diamminedichloroplatinum (DDP) in disseminated extragonadal germ cell tumors. A southwest oncology group study
1980
Aclacinomycin A Phase II Evaluation in Bronchogenic Squamous-Cell Carcinoma
1987
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.
1987